NR3C1 and prostate cancer: The biodistribution of 18F-GR02 (∼11 MBq/mouse) was evaluated in intact male nu/nu mice bearing subcutaneous PC3 or DU145 tumors, two prostate cancer models with endogenous and approximately equivalent GR expression (Figure 4A).